摘要
The prognostic value of albumin changes between diagnosis and end-of-treatment (EoT) in diffuse large B-cell lymphoma (DLBCL) remains unknown. We retrospectively analyzed 574 de novo DLBCL patients treated with R-CHOP from our and two other centers. All patients were divided into a training cohort (n = 278) and validation cohort (n = 296) depending on the source of the patients. Overall survival (OS) and progression-free survival (PFS) were analyzed by the method of Kaplan-Meier and Cox proportional hazard regression model. In the training cohort, 163 (58.6%) patients had low serum albumin at diagnosis, and 80 of them were present with consecutive hypoalbuminemia at EoT. Patients with consecutive hypoalbuminemia showed inferior OS and PFS (p = 0.010 and p = 0.079, respectively). Similar survival differences were also observed in the independent validation cohort (p = 0.006 and p = 0.030, respectively). Multivariable analysis revealed that consecutive hypoalbuminemia was an independent prognostic factor OS [relative risk (RR), 2.249; 95% confidence interval (CI), 1.441-3.509, p < 0.001] and PFS (RR, 2.001; 95% CI, 1.443-2.773, p < 0.001) in all DLBCL patients independent of IPI. In conclusion, consecutive hypoalbuminemia is a simple and effective adverse prognostic factor in patients with DLBCL, which reminds us to pay more attention to patients with low serum albumin at EoT during follow-up.
学科与关键词
- Hypoalbuminemia predicts inferior outcome in patients with AIDS-related lymphomaZhang, Jinxin; Xie, Zhiman; Cai, Shaohang; Qin, Shanfang; Ruan, Guangjing; Lu, Aili; Wu, Yihua; Chen, Juanjuan*; Peng, Jie*Infectious Agents and Cancer, 2022, 17(1): 33.被引 1
- A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center studyWei, Li; Gao, Yuting; Prochazka, Katharina Theresa; Liu, Rongqiu; Wang, Liang; Liu, Boyang; He, Yingzhi; Bertero, Luca; Pellerino, Alessia; Cassoni, Paola; Tamagnone, Luca; Deutsch, Alexander J.; Zhan, Huien; Lai, Jing; Kim, Seok Jin*; You, Hua*Journal of Neuro-Oncology, 2023, 163(2): 301-311.被引 3
- A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort studyCai, Jun; Tian, Xiaopeng; Ma, Shuyun; Zhong, Liye; Li, Wenyu; Wang, Liang; Guo, Linlang; Li, Zhihua; Wu, Yudan; Zhong, Guangzheng; Huang, Huiqiang; Xia, Zhongjun; Xia, Yi; Liu, Panpan; Su, Ning; Fang, Yu; Zhang, Yuchen; Cai, Qingqing*British Journal of Cancer, 2021, 125(3): 402-412.被引 4
